Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Korean Journal of Dermatology ; : 750-751, 2016.
Article in Korean | WPRIM | ID: wpr-24859

ABSTRACT

No abstract available.


Subject(s)
Axilla , Paget Disease, Extramammary
2.
Korean Journal of Dermatology ; : 413-414, 2015.
Article in Korean | WPRIM | ID: wpr-37273

ABSTRACT

No abstract available.


Subject(s)
Skin Diseases, Vesiculobullous
3.
Korean Journal of Dermatology ; : 430-432, 2014.
Article in Korean | WPRIM | ID: wpr-156840

ABSTRACT

No abstract available.


Subject(s)
Lipoma , Scalp
4.
Korean Journal of Dermatology ; : 58-61, 2011.
Article in Korean | WPRIM | ID: wpr-171984

ABSTRACT

Vitamin K1 dermatitis is a cutaneous adverse reaction to vitamin K1, and this malady presents as an erythematous eczematoid patch or pseudoscleroderma. At first, liver disease was thought to be related to vitamin K1 dermatitis. However, it is no longer considered as being related to liver disease due to the increasing case reports of patients with vitamin K1 dermatitis and who are without liver disease. Type IV hypersensitivity reaction was suspected to be the cause of this reaction. This disease can be easily ignored because of its low incidence. We hereby report on a case of vitamin K1 dermatitis that was confirmed by a skin test.


Subject(s)
Humans , Dermatitis , Hypersensitivity, Delayed , Incidence , Liver Diseases , Skin Tests , Vitamin K 1 , Vitamins
5.
Korean Journal of Dermatology ; : 295-302, 2009.
Article in Korean | WPRIM | ID: wpr-90894

ABSTRACT

BACKGROUND: Topical 5% minoxidil solution stimulates new hair growth and it helps stop the loss of hair on individuals with androgenetic alopecia (AGA). OBJECTIVE: We wanted to assess the efficacy and safety of topical 5% minoxidil solution for treating Korean men with AGA. METHODS: This was a 24-week, open label, clinical trial that was conducted at 14 university dermatologic centers nationwide throughout South Korea as a multicenter study of the Korean Hair Research Society. The eligible subjects for this study were 18- to 65 year-old men with androgenetic alopecia, as defined by the Norwood scale as type III vertex, IV and IVA. A total of 175 men (20~62 years old) with AGA applied topical 5% minoxidil solution twice daily. Efficacy was evaluated by 1) the total hair count per 1 cm2 and 2) the mean hair diameter and 3) the patient assessment and 4) the investigator assessment of the change in scalp coverage and the benefit of treatment. RESULTS: At week 24 as compared with baseline, there was a statistically significant increase in the total hair counts and the mean hair diameter (p<.0001). Topical 5% minoxidil solution helped improve the investigator and patient assessments. The topical 5% minoxidil solution was well tolerated over a 24-week period. CONCLUSION: We believe that topical 5% minoxidil solution is a safe and effective drug for Korean men with AGA.


Subject(s)
Humans , Male , Alopecia , Hair , Minoxidil , Republic of Korea , Research Personnel , Scalp
SELECTION OF CITATIONS
SEARCH DETAIL